bluebird bio’s beta-thalassaemia gene therapy rejected by NICE
admin 12th February 2021 Uncategorised 0NICE determined that there were uncertainties around the cost-effectiveness of the therapy
More: bluebird bio’s beta-thalassaemia gene therapy rejected by NICE
Source: News